mycophenolic acid
NDC 85972-161, mycophenolic acid, tablet, delayed release, from Stellon Biotech Inc..
- Product NDC
- 85972-161
- Status
- Listed
- Labeler
- Stellon Biotech Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211173
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85972-161 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MYCOPHENOLATE SODIUM180 mg/1
Pharmacologic classes
Antimetabolite Immunosuppressant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85972-161-12 | 85972016112 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (85972-161-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4b153bb3-fb7a-472d-b73e-e630e50c5633
Use it
Look up 85972-161 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85972-161 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85972-161. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.